SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published:March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like Study reveals surprising connection between herpes and Alzheimer’s January 2, 2025 Redefining early detection for type 1 diabetes January 28, 2026 Stem cell study identifies universal checkpoint controlling cell identity April 8, 2026